Rituximab-Containing Immunochemotherapy for Burkitt's Lymphoma (BL) and High-Grade B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and BL
20 Years
N/A
Both
Burkitt's Lymphoma, High-grade B-cell Lymphoma
Trial Information
Rituximab-Containing Immunochemotherapy for Burkitt's Lymphoma (BL) and High-Grade B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and BL
Inclusion criteria
1. pathologically confirmed BL or BL-U by WHO 2008 criteria
2. age >20 yrs
3. received rituximab+chemotherapy as first-line treatment
4. with measurable or evaluable lesion
5. with complete set of clinical and laboratory data for the analysis
Inclusion Criteria:
1. pathologically confirmed Burkitt's lymphoma (BL) or High grade B-cell lymphoma,
unclassifiable, with features intermediate between diffuse large B-cell lymphoma and
BL (BL-U) by WHO 2008 criteria
2. age >20 yrs
3. received rituximab+chemotherapy as first-line treatment
4. with measurable or evaluable lesion
Exclusion Criteria:
1. patients with BL or BL-U previously treated with rituximab
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Outcome Measure:
Event-free survival
Outcome Description:
Event-free survival is measured from the time from treatment initiation to any treatment failure including disease progression, or discontinuation of treatment for any reason (eg, disease progression, toxicity, patient preference, initiation of new treatment without documented progression, or death)
Outcome Time Frame:
one year
Safety Issue:
No
Principal Investigator
Suk Jin Kim, MD, PhD
Investigator Role:
Study Director
Investigator Affiliation:
Samsung Medical Center, Seoul, Korea
Authority:
Korea: Institutional Review Board
Study ID:
CISL-1203
NCT ID:
NCT01809600
Start Date:
February 2013
Completion Date:
August 2013
Related Keywords:
- Burkitt's Lymphoma
- High-grade B-cell Lymphoma
- Burkitt Lymphoma
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
Name | Location |
|---|
